Johnson & Johnson JNJ

$270.47 +3.33 (1.25%)

Valuation

Market cap
651,105,152,000
Revenue TTM
$94,193,000,000
Net income TTM
$26,804,000,000
P/E (trailing)
25.08
P/E (forward)
24.03
Profit margin
28.46%
Debt to equity
0.44

Trading

Volume
11,925,300
Avg volume
7,611,122
Day's range
$269.47 – $272.50
Shares out
2,407,310,000
Stochastic %K
23%
Beta
0.22
Analysts
Moderate Buy
Price target
$284.24

Price

Company profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular...

Show more

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
732 524 0400
Website
https://www.jnj.com
Address
One Johnson & Johnson Plaza, New Brunswick, United States

Latest news

Stocktwits

Obaretinosazze Nov 22, 8:02 PM
$JNJ https://www.nasdaq.com/articles/johnson-johnson-track-101-billion-2026-sales-dividend-king-still-buy
0 replies
CrazyCajun7 Nov 22, 7:58 PM 0 replies
DangerFUD Nov 22, 7:51 PM
$SLS $MRK when I day-dream about Merck buying SLS….the “WebuyAnyCar “song creeps in my head, whenever I see the $JNJ ticket pop up as trending. 🤣🤣🤣
0 replies
PIPEX Nov 22, 7:20 PM
$JNJ why is this moving up?
1 replies
GoPatzGo123 Nov 22, 7:10 PM
$ONCY its too bad we weren't trending both $MRK and $JNJ may make a bid for $SLS for its phase 3 regal blood cancer drug. We have absolutely no interest at all from BP or else we wouldn't be trading in the 0.30's ...that's a reflection on Jared's performance
0 replies
Rookie100 Nov 22, 7:04 PM
$SLS wtf $MRK , $JNJ , $ABBV trending not $SLS
2 replies
Lambster2 Nov 22, 6:45 PM
$SLS It's crazy that $MRK and $JNJ are trending number one and two because of $SLS speculation and $SLS is not in the top 10.
2 replies
CrazyCajun7 Nov 22, 6:45 PM 0 replies